Vesiculab

Biomedical Research Servicesvesiculab.com

Vesiculab is a private UK life-sciences company based in Nottingham (1–10 employees) that provides solutions for extracellular vesicle research, nanomedicines, and gene therapy, serving academic and industrial researchers in these adjacent fields.

Company typePrivate
Founded-
HeadquartersNottingham, United Kingdom
Headcount1–10
GTM typeB2B
OfferingServices

Vesiculab firmographics

Firmographics

Name: Vesiculab
Website: https://vesiculab.com
Company type: Private
Headcount range: 1–10 employees
Short description: Vesiculab is a private UK life-sciences company based in Nottingham (1–10 employees) that provides solutions for extracellular vesicle research, nanomedicines, and gene therapy, serving academic and industrial researchers in these adjacent fields.
Ownership category
akta.pro rank

Vesiculab industry classification

Industry

Product category: Biomedical Research Services
NAICS: Scientific Research and Development Services (5417)
akta.pro industry: PRIMARYHLAGADAK
Material Characterization & Spectroscopy (NMR/FTIR/MS)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical Services
SECONDARYHLAGAGAE
Process Development & Tech Transfer (Upstream/Downstream/MSAT)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

Keywords

Extracellular vesicle research
Nanomedicine development
Gene therapy tools
Vesicle analysis services
Biomedical research solutions

Where Vesiculab is headquartered

Location

Headquarters

HQ city: Nottingham
HQ country: United Kingdom
HQ region: Europe

Markets served

Vesiculab business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Operations, Technology or R&D, Marketing or Sales

Vesiculab product offering

Product offering

Core offering

Vesiculab provides solutions for extracellular vesicle research, nanomedicines, and gene therapy. The company operates in the life sciences sector, supporting research and development activities in vesicle biology, nanoscale therapeutics, and gene-based treatments. With a small team based in Nottingham, United Kingdom, it serves as a specialized provider in these frontier research areas.

Differentiator

Problem solved

Functional benefit

Companies that use Vesiculab

Customer profile

Ideal customer profiles1 record

Vesiculab technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Vesiculab competitors and assessment

Company assessment

Broad incumbents

Lonza: Lonza is a global CDMO with significant cell and gene therapy manufacturing services, a tangential but comparable presence in the therapeutic applications Vesiculab also serves.
Bio-Techne: Bio-Techne offers a broad portfolio of life-sciences reagents including EV-related antibodies, ELISAs, and purification kits, competing across multiple of Vesiculab's target segments as part of a much larger catalog.
Thermo Fisher Scientific: Thermo Fisher supplies a comprehensive suite of life-sciences reagents, instruments, and services spanning extracellular vesicle, gene therapy, and nanomedicine workflows — a broad incumbent against which Vesiculab must differentiate.
Merck KGaA (Life Science / MilliporeSigma): MilliporeSigma supplies reagents, kits, and consumables used in EV research and gene therapy development, and serves as a default vendor for many of the same academic and biopharma buyers.
Miltenyi Biotec: Miltenyi is a major cell and gene therapy tools provider with established EV isolation reagents (e.g., ExoFlow) — a broader incumbent whose portfolio overlaps with Vesiculab's targeted focus areas.

Direct peers

System Biosciences (SBI): SBI sells reagents, kits, and services specifically for extracellular vesicle isolation, characterization, and engineering — the closest direct comparable to Vesiculab's EV research solutions.
NanoFCM: NanoFCM provides flow cytometry instrumentation purpose-built for nanoscale particles including extracellular vesicles, directly overlapping with Vesiculab's EV research offering.
Izon Science: Izon produces tunable resistive pulse sensing (TRPS) instruments and consumables for nanoparticle and extracellular vesicle analysis, competing head-to-head in the EV characterization workflow.

Emerging players

Precision NanoSystems (Cytiva): Precision NanoSystems specializes in lipid nanoparticle technology for nanomedicine and gene therapy delivery — overlapping with two of Vesiculab's three focus areas and now operating within Cytiva.
Exosomics: Exosomics develops EV-based diagnostics and provides EV isolation/analysis tools, making it a focused, smaller-scale peer in the same extracellular vesicle research ecosystem.

Market position

Customer concentration

Vesiculab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vesiculab leadership team

Management profile

Number of profiles

Vesiculab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vesiculab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vesiculab

What does Vesiculab do?

When was Vesiculab founded?

Vesiculab was founded in -1. It employs 1 to 10 people.

Where is Vesiculab based?

Vesiculab is headquartered in Nottingham, United Kingdom, in the Europe region.

Who are Vesiculab's main competitors?

Broad incumbents on record are Lonza, Bio-Techne, Thermo Fisher Scientific, Merck KGaA (Life Science / MilliporeSigma) and Miltenyi Biotec. Direct peers are System Biosciences (SBI), NanoFCM and Izon Science. Emerging players are Precision NanoSystems (Cytiva) and Exosomics.

Does Vesiculab have an API?

No public API is recorded for Vesiculab.

What industry is Vesiculab in?

Vesiculab's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGADAK, Material Characterization & Spectroscopy (NMR/FTIR/MS), with a secondary code of HLAGAGAE, Process Development & Tech Transfer (Upstream/Downstream/MSAT). Its NAICS code is 5417.